Proctoscopy

PROCEDURE3 trials

Conditions

AIDS-Related Anal CarcinomaAnal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell CarcinomaAnal Squamous Cell CarcinomaCervical CancerHIV Infection

Phase 1

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

CompletedNCT01485731

University of MiamiCervical Cancer

Start: 2012-01-31End: 2015-02-28Updated: 2015-06-03

Phase 2

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Active, not recruitingNCT04929028

National Cancer Institute (NCI)AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma +7

Start: 2022-08-09End: 2031-09-15Target: 40Updated: 2026-04-03

Phase 3

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Active, not recruitingNCT03233711

National Cancer Institute (NCI)Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma +2

Start: 2018-07-05End: 2027-12-31Target: 344Updated: 2026-04-03

Related Papers

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Journal for ImmunoTherapy of Cancer2024-01-0110 citations

Phase I trial of nelfinavir added to cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.